Dr. Heidi Jordan
Medical Oncology
Texas, United States
Dr. Jordan practices at 2 locations. See details below.About Dr. Jordan
Dr. Jordan is an Medical Oncology Specialist in Grapevine and Irving, Texas. She graduated from University Of Texas Medical Branch At Galveston in 1996. Dr. Jordan accepts Medicare approved amount as full payment.
The medical group (Texas Onco) Dr. Jordan works with accepts Medicare approved amount as full payment.
Full Name
Heidi Jordan
Specialty
Medical Oncology
School
University Of Texas Medical Branch At Galveston
Graduated class of
1996
Locations
NPI
1386603744
PAC ID
2147483647
Clinician Enrollment ID
I20040818000297
Cities
2
Number of cities where Dr. Jordan has officesOffices
2
Number of officesHospitals
1
Number of hospitalsOffice Locations
GRAPEVINE Office
Phone: (817) 251-9080
1631 Lancaster Dr
Suite 150
Grapevine, TX - 76051-3586
IRVING Office
Phone: (469) 513-5500
1501 W Royal Ln
Irving, TX - 75063-3213
Hospitals
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
CMS Certification Number: 450563
Doctors and Clinicians Utilization Data
Specialty | HCPCS code | Code description | Service Count | Beneficiary count |
---|---|---|---|---|
Medical Oncology | 36415 | Insertion of needle into vein for collection of blood sample | 1564 | 380 |
Medical Oncology | 74177 | CT scan of abdomen and pelvis with contrast | 63 | 51 |
Medical Oncology | 80053 | Blood test, comprehensive group of blood chemicals | 1448 | 381 |
Medical Oncology | 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 1632 | 397 |
Medical Oncology | 96366 | Infusion into a vein for therapy, prevention, or diagnosis | 145 | 42 |
Medical Oncology | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 62 | 14 |
Medical Oncology | 96415 | Infusion of chemotherapy into a vein | 233 | 41 |
Medical Oncology | G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation | 571 | 89 |
Medical Oncology | J0897 | Injection, denosumab, 1 mg | 3540 | 16 |